2. ความปวด ***** PAIN
An unpleasant sensory and
emotional experience associated with
actual or potential tissue damage, or
described in terms of such damage
ประสบการณ์ที่ไม่สบายกาย ไม่สบายใจ ที่เกิดจากการ
บาดเจ็บของเนื้อเยื่อหรือศักยภาพที่จะทาให้มีการบาดเจ็บ
ของเนื้อเยื่อ หรือประหนึ่งว่ามีการบาดเจ็บ
3. Facts about cancer pain
Frequency of occurrence varies with ;
• stage of the disease
• primary site of the tumor
Frequency of occurrence varies with ;
• stage of the disease
• primary site of the tumor
Moderate or severe pain occurs in 30 - 40%
of the patients at the time of diagnosis and
60 - 100% with advanced cancer
Moderate or severe pain occurs in 30 - 40%
of the patients at the time of diagnosis and
60 - 100% with advanced cancer
Most cancer patients have more than
one pain
Most cancer patients have more than
one pain
5. Causes of Pain
1. Due to tumor involvement 78%
• bone, nerve, soft tissue, viscera
2. Associated with treatment 19%
• diagnosis and staging procedures
• surgery
• chemotherapy; mucositis, phlebitis,
tissue necrosis, myalgia, arthralagia
• radiotherapy; mucositis, neuropathy,
myelopathy
6. 3. Due to general illness but not cancer
(10%)
• constipation
• pressure
• gastric distention
• reflux esophagitis
• bladder spasm (with catheterization)
• musculoskeletal pain
• thrombosis and embolism
• mucositis
• post herpetic neuralgia
4. Unrelated to cancer or its
treatment(10%)
Causes of Pain
13. Pain Assessment
• Location of all the pain
• How the pain feels
• Intensity of the pain
• When, frequency, duration
• What ease the pain, what worsen
the pain
• Medications taking
• Side effects of pain medications
• Quality of life issues
• Pain diary!
14.
15. Pain Assessment
• Chronicity: Acute vs Chronic pain
• Pain intensity
• Pathophysiology:
somatic vs. visceral
nociceptive vs. neuropathic
• Course of the disease: continuous,
breakthrough, incident pain.
• Pain syndrome: brain metastasis,
bone pain
16. ChronicityChronicity
Acute pain Chronic
pain
Onset well-defined ill-defined
Cause acute injury or
illness
chronic
progress
Duration days/weeks
predictable
months/years
unpredictable
Physiologic
al
sympathetic over
activity
no sympathetic
over activity
17. Acute pain Chronic
pain
Affective anxiety depression
Cognitive meaningful meaningless
Behavioral inactivity until
recovery
changes in life
style
changes in
functional
ability
withdrawn
Treatment cause
temporary
analgesics
supportive
regular
analgesics
18. Categoral scales
• Verbal rating scale (VRS)
(verbal descriptor scale)
• 2 – 7 words
None Mild Moderate Severe
• Pain relief
None Slight Moderate Good Complete
21. Pain Assessment
• Chronicity: Acute vs Chronic pain
• Pain intensity
• Pathophysiology:
somatic vs. visceral
nociceptive vs. neuropathic
• Course of the disease: continuous,
breakthrough, incident pain.
• Pain syndrome: brain metastasis,
bone pain
22. Pathophysiology
• Nociceptive ( somatic and visceral )
– constant and well localized
– aching, throbbing, gnawing
– vague in distribution and quality, deep, dull,
aching, dragging, squeezing, pressure-like
• Neuropathic
– may be constant, steady, and spontaneously
maintained, intermittent, shock-like, shooting,
lancinating, electrical, burning, tingling, numbing,
pressing, squeezing, and itching
– dysesthesia, hyperalgesia, allodynia,
hyperesthesia, hyperpathia
23. Neuropathic Pain
• Hardest mechanism to treat
• Diagnose straightforward: nerve or
dermatome distribution, no local tenderness
but referred
• Two types
– Mixed: nociceptive/neuropathic due to tumor
invasion or compression of nerve pathway;
brachial, lumbosacral plexus, chest wall invasion,
spinal cord compression
– Pure (Deafferentation): no nociceptive element;
PHN, post-thoracotomy syndrome, phantom pain
24.
25. Bone Pain
• Most common cause of pain in advanced
cancer
• Most common malignancies metastasize to
bone: breast, prostate, lung, kidney, thyroid
• Common problems: chronic bone pain,
pathologic fracture, hypercalcemia
• Treatment includes: NSAIDs, opioids,
radiotherapy, Strontium-89, bisphosphonate,
corticosteroids, calcitonin.
• Early Orthopedic consultation and treatment
is important
28. Principle of Analgesic Use
• Define the nature of pain
• Maximize the current regimen
• Understand the drug Pharmacology
– Speed of onset and duration of action
– Management of side effects
– Beware of the drug interactions
• Emphasize patient education
30. WHO Analgesic Ladder (1992--)
Non-opioid
+ Adjuvants
Opioid for
mild to moderate pain
+ Non-opioid + Adjuvants
Opioid for
Moderate to severe pain
+ Non-opioid + Adjuvants
Pain
Pain persist
Pain persist
Freedom from
cancer pain
32. Essential concepts in the WHO
approach to drug therapy
• By the mouth
• By the clock
• By the ladder
• For the individual
• With attention to
detail
33. Principles of analgesic used
• Administer on strict schedule to
prevent pain, not PRN
• Give instructions for treatment of
breakthrough pain
• Following analgesic ladder
• Review & assess
34. GENERAL RECOMMENDATIONS
• Oral medications should be used as the
first line approach.
• Any proposed systemic regimen must
be individualized.
• There is no predetermined maximum
dose of an opioid.
• Dose titration may be required
periodically.
36. Nausea
• Moderate to severe 8.3 – 18.3%
• Direct effect of opioids on CTZ
• Decrease quality of life, limit food
intake
• Other underlying conditions; electrolyte
imbalance, dehydration, brain metastasis,
intestinal obstruction, ileus, chemotherapy,
tumor of the GI, constipation, infection,
blood poisoning, kidney problems, anxiety,
etc.
37. Nausea
• Usually subside within few days
• Treatment;
– Metoclopramide ( block in GI tract and CTZ)
– Butyrophenones (haloperidol, droperidol) (at
CTZ)
– Phenothiazine (CTZ, GI, vestibular)
– Antihistamine (dramamine,hydroxyzine) (H1
blockade and VC)
– Hyoscine, scopolamine (VC and GI)
– Ondansetron (5HT3 in GI and CTZ)
– Benzodiazepine (lorazepam) GABA agonist
38. Constipation
• The most troublesome, almost
everyone is involved, will not develop
tolerance
39. Treatment of Constipation
• Stimulant laxatives
• Senokot 1 tab hs – 4 tab tid orally
• Dulcolax 1 tab hs – 3 tab tid orally
• Bulk-forming laxatives
• Metamucil 1 tsp in 8 oz water OD – tid
• Bran
• Saline or osmotic cathartics
• MOM 15 – 40 ml OD – bid
• Magnesium citrate solution 240 ml OD
40. CNS effects
• Aggravating factors;
– High doses opioid
– Psychoactive drugs
– Renal failure
• Slow down of cognitive function, sedation,
hallucination and delirium, fluctuation of
consciousness, change in sleep-wake cycle,
agitation, myoclonus.
• Improve spontaneously
41. CNS effects
• Role of M-3-G
• Management;
– Opioid rotation
– Dose reduction
– Circadian modulation
– Hydration
– Psychostimulants
– Other drugs; haloperidol, midazolam,
baclofen, clonazepam,clonidine
43. ADJUVANTS
DRUGS
- Anticonvulsants
- Antidepressants
- Local anesthetics
- Corticosteroids
- Antihistaminics
- Muscle relaxants
- Psychostimulants
- Drug action on bone
INDICATIONS
- neuropathic pain
- neuropathic pain
- neuropathic pain
- multiple
- coanalgesic, antiemetic
- muscle spasm
- opioid sedation
- bone pain
44. Antidepressants
• Used in neuropathic pain ; several studies in
Diabetic neuropathy, Post-herpetic neuralgia,
phantom limb pain, migraine headache
• Reduce insomnia and anxiety
• 1-2 weeks lag time for clinical effects
• Start 10-20 mg hs
• Escalated 4-5 day intervals to doses 100- 150
mg
• Abrupt escalation not recommended